Cargando…
Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus
BACKGROUND: Progressive pancreatic β-cell dysfunction is a fundamental part of the pathology of type 2 diabetes mellitus (T2DM). Cellular therapies offer novel opportunities for the treatment of T2DM to improve the function of islet β-cells. AIM: To evaluate the effectiveness and safety of human umb...
Autores principales: | Lian, Xiao-Fen, Lu, Dong-Hui, Liu, Hong-Li, Liu, Yan-Jing, Han, Xiu-Qun, Yang, Yang, Lin, Yuan, Zeng, Qing-Xiang, Huang, Zheng-Jie, Xie, Feng, Huang, Cai-Hao, Wu, Hong-Mei, Long, Ai-Mei, Deng, Ling-Ping, Zhang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606793/ https://www.ncbi.nlm.nih.gov/pubmed/36312002 http://dx.doi.org/10.4239/wjd.v13.i10.877 |
Ejemplares similares
-
Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial
por: Lian, Xiao-Fen, et al.
Publicado: (2023) -
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE
por: Kamen, Diane L, et al.
Publicado: (2022) -
Abstract 14 Umbilical Cord Mesenchymal Stromal/Stem Cells Application for Spasticity Treatment in Multiple Sclerosis
por: Petriv, Taras, et al.
Publicado: (2022) -
Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
por: Wei, Fengtao, et al.
Publicado: (2021) -
Abstract 6 Combined Umbilical Cord Mesenchymal Stromal/Stem Cell Application For Primary Torsion Dystonia Treatment (Case Report)
por: Petriv, Taras, et al.
Publicado: (2023)